11-2884935-AGCCGGGGCCGGGGCCGGG-AGCCGGGGCCGGGGCCGGGGCCGGG

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_001122630.2(CDKN1C):​c.516_521dupCCCGGC​(p.Ala174_Pro175insProAla) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000544 in 900,920 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A174A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00021 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000027 ( 1 hom. )

Consequence

CDKN1C
NM_001122630.2 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: -0.0170

Publications

0 publications found
Variant links:
Genes affected
CDKN1C (HGNC:1786): (cyclin dependent kinase inhibitor 1C) This gene is imprinted, with preferential expression of the maternal allele. The encoded protein is a tight-binding, strong inhibitor of several G1 cyclin/Cdk complexes and a negative regulator of cell proliferation. Mutations in this gene are implicated in sporadic cancers and Beckwith-Wiedemann syndorome, suggesting that this gene is a tumor suppressor candidate. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
CDKN1C Gene-Disease associations (from GenCC):
  • Beckwith-Wiedemann syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • IMAGe syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, G2P, Ambry Genetics
  • rhabdomyosarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • Beckwith-Wiedemann syndrome due to CDKN1C mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • intrauterine growth restriction-short stature-early adult-onset diabetes syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Silver-Russell syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001122630.2
BP6
Variant 11-2884935-A-AGCCGGG is Benign according to our data. Variant chr11-2884935-A-AGCCGGG is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 412842.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000207 (28/135374) while in subpopulation SAS AF = 0.000477 (2/4194). AF 95% confidence interval is 0.00014. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 28 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDKN1CNM_001122630.2 linkc.516_521dupCCCGGC p.Ala174_Pro175insProAla disruptive_inframe_insertion Exon 2 of 4 ENST00000440480.8 NP_001116102.1 P49918-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDKN1CENST00000440480.8 linkc.516_521dupCCCGGC p.Ala174_Pro175insProAla disruptive_inframe_insertion Exon 2 of 4 1 NM_001122630.2 ENSP00000411257.2 P49918-2

Frequencies

GnomAD3 genomes
AF:
0.000207
AC:
28
AN:
135374
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000243
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000358
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000477
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000178
Gnomad OTH
AF:
0.000542
GnomAD4 exome
AF:
0.0000274
AC:
21
AN:
765546
Hom.:
1
Cov.:
11
AF XY:
0.0000331
AC XY:
12
AN XY:
362946
show subpopulations
African (AFR)
AF:
0.0000684
AC:
1
AN:
14626
American (AMR)
AF:
0.00
AC:
0
AN:
4428
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
8218
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12798
South Asian (SAS)
AF:
0.00
AC:
0
AN:
14462
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
13096
Middle Eastern (MID)
AF:
0.00104
AC:
2
AN:
1918
European-Non Finnish (NFE)
AF:
0.0000255
AC:
17
AN:
667252
Other (OTH)
AF:
0.0000348
AC:
1
AN:
28748
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000207
AC:
28
AN:
135374
Hom.:
0
Cov.:
32
AF XY:
0.000213
AC XY:
14
AN XY:
65760
show subpopulations
African (AFR)
AF:
0.000243
AC:
9
AN:
37110
American (AMR)
AF:
0.000358
AC:
5
AN:
13968
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3200
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4532
South Asian (SAS)
AF:
0.000477
AC:
2
AN:
4194
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
7746
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
254
European-Non Finnish (NFE)
AF:
0.000178
AC:
11
AN:
61720
Other (OTH)
AF:
0.000542
AC:
1
AN:
1846
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Sep 27, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 20, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In-frame insertion of 2 amino acids in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge -

Beckwith-Wiedemann syndrome Benign:1
Nov 29, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer Benign:1
Sep 11, 2024
Mendelics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following: it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease, and/or has normal protein function, and/or has lack of segregation with disease, and/or has been detected in co-occurrence with known pathogenic variant, and/or has lack of disease association in case-control studies, and/or is located in a region inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.017
Mutation Taster
=82/18
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs878853629; hg19: chr11-2906165; API